Evidence map›Paper›PMID 29599744›Full record

ArticleFrontiers in neurology2018

Myopathy With

Zhiyv Niu, Carly Sabine Pontifex, Sarah Berini, Leslie E Hamilton, Elie Naddaf, Eric Wieben, Ross A Aleff, Kristina Martens, Angela Gruber, Andrew G Engel and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Evaluation of aggrephagy markers in myofibrillar myopathies.Acta neuropathologica communications · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Zhiyv NiuDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Carly Sabine PontifexDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Sarah BeriniDepartment of Neurology, Mayo Clinic, Rochester, MN, United States.
Leslie E HamiltonDepartment of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
Elie NaddafDepartment of Neurology, Mayo Clinic, Rochester, MN, United States.
Eric WiebenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States.
Ross A AleffDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, United States.
Kristina MartensDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Angela GruberPrevention Genetics, Marshfield, WI, United States.
Andrew G EngelDepartment of Neurology, Mayo Clinic, Rochester, MN, United States.
Gerald PfefferDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Margherita MiloneDepartment of Neurology, Mayo Clinic, Rochester, MN, United States.
Mayo Clinic in Arizona · USUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study is to identify the molecular defect of three unrelated individuals with late-onset predominant distal myopathy; to describe the spectrum of phenotype resulting from the contributing role of two variants in genes located on two different chromosomes; and to highlight the underappreciated complex forms of genetic myopathies. PATIENTS AND

methodsClinical and laboratory data of three unrelated probands with predominantly distal weakness manifesting in the sixth-seventh decade of life, and available affected and unaffected family members were reviewed. Next-generation sequencing panel, whole exome sequencing, and targeted analyses of family members were performed to elucidate the genetic etiology of the myopathy.

resultsGenetic analyses detected two contributing variants located on different chromosomes in three unrelated probands: a heterozygous pathogenic mutation in

conclusionThe findings indicate that all the affected individuals have a myopathy associated with both variants in

Indexed as

distal myopathymyofibrillar myopathyrespiratory insufficiencyrimmed vacuolesSQSTM1TIA1

Identifiers

PMID29599744
PMCPMC5868303
OpenAlexW2790540308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.